197 related articles for article (PubMed ID: 15794856)
21. New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY).
Baró C; Salido M; Espinet B; Astier L; Domingo A; Granada I; Millà F; Carrió A; Costa D; Luño E; Hernández JM; Campo E; Florensa L; Ferrer A; Salar A; Bellosillo B; Besses C; Serrano S; Solé F
Leuk Res; 2008 May; 32(5):727-36. PubMed ID: 18023866
[TBL] [Abstract][Full Text] [Related]
22. [Lymphoplasmacytic lymphoma with Waldenström's macroglobulinemia: a clinicopathological and immunophenotypic study of 40 Chinese patients].
Liang DN; Li GD; Dai L; Huang J; Wang WY; Feng WH; Li FY; Liao DY
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):728-32. PubMed ID: 20079010
[TBL] [Abstract][Full Text] [Related]
23. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
Owen RG
Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
[TBL] [Abstract][Full Text] [Related]
24. Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32.
Boonstra R; Bosga-Bouwer A; van Imhoff GW; Krause V; Palmer M; Coupland RW; Dabbagh L; van den Berg E; van den Berg A; Poppema S
Mod Pathol; 2003 Dec; 16(12):1210-7. PubMed ID: 14681321
[TBL] [Abstract][Full Text] [Related]
25. Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition.
McMaster ML; Giambarresi T; Vasquez L; Goldstein AM; Tucker MA
Clin Lymphoma; 2005 Mar; 5(4):230-4. PubMed ID: 15794854
[TBL] [Abstract][Full Text] [Related]
26. Uncommon cytogenetic findings in a case of splenic marginal zone lymphoma with aggressive clinical course.
Viaggi S; Abbondandolo A; Carbone M; Ottaggio L; Sessarego M; Zupo S; Zunino A
Cancer Genet Cytogenet; 2004 Jan; 148(2):133-6. PubMed ID: 14734224
[TBL] [Abstract][Full Text] [Related]
27. [Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma].
Zou D; Yi S; Liu H; Li Z; Lyu R; Liu W; Ru K; Zhang P; Chen H; Qi J; Zhao Y; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):493-6. PubMed ID: 26134015
[TBL] [Abstract][Full Text] [Related]
28. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.
Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E
Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566
[TBL] [Abstract][Full Text] [Related]
29. High-resolution genomic analysis in Waldenström's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas.
Braggio E; Keats JJ; Leleu X; Wier SV; Jimenez-Zepeda VH; Schop RF; Chesi M; Barrett M; Stewart AK; Dogan A; Bergsagel PL; Ghobrial IM; Fonseca R
Clin Lymphoma Myeloma; 2009 Mar; 9(1):39-42. PubMed ID: 19362969
[TBL] [Abstract][Full Text] [Related]
30. IgM myeloma: case report with immunophenotypic profile.
Haghighi B; Yanagihara R; Cornbleet PJ
Am J Hematol; 1998 Dec; 59(4):302-8. PubMed ID: 9840911
[TBL] [Abstract][Full Text] [Related]
31. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
Vitolo U; Ferreri AJ; Montoto S
Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
[TBL] [Abstract][Full Text] [Related]
32. Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization.
Andersen CL; Gruszka-Westwood A; Atkinson S; Matutes E; Catovsky D; Pedersen RK; Pedersen BB; Pulczynski S; Hokland P; Jacobsen E; Koch J
Cancer Genet Cytogenet; 2005 Jan; 156(2):122-8. PubMed ID: 15642391
[TBL] [Abstract][Full Text] [Related]
33. Prognostic relevance of 6q deletion in Waldenström's macroglobulinemia: a multicenter study.
Chang H; Qi C; Trieu Y; Jiang A; Young KH; Chesney A; Jani P; Wang C; Reece D; Chen C
Clin Lymphoma Myeloma; 2009 Mar; 9(1):36-8. PubMed ID: 19362968
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological correlates of IgM paraproteinemias.
Owen RG; Parapia LA; Higginson J; Misbah SA; Child JA; Morgan GJ; Jack AS
Clin Lymphoma; 2000 Jun; 1(1):39-43; discussion 44-5. PubMed ID: 11707811
[TBL] [Abstract][Full Text] [Related]
35. Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implications.
Paulus A; Chitta KS; Wallace PK; Advani PP; Akhtar S; Kuranz-Blake M; Ailawadhi S; Chanan-Khan AA
PLoS One; 2015; 10(4):e0122338. PubMed ID: 25853860
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical phenotyping of plasma cells in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia is comparable to flow cytometric techniques.
Howard MT; Hodnefield J; Morice WG
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):96-8. PubMed ID: 21454202
[TBL] [Abstract][Full Text] [Related]
37. The malignant clone in Waldenstrom's macroglobulinemia.
Kriangkum J; Taylor BJ; Mant MJ; Treon SP; Belch AR; Pilarski LM
Semin Oncol; 2003 Apr; 30(2):132-5. PubMed ID: 12720122
[TBL] [Abstract][Full Text] [Related]
38. The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia.
Al-Katib AM; Mensah-Osman E; Aboukameel A; Mohammad R
Semin Oncol; 2003 Apr; 30(2):313-7. PubMed ID: 12720160
[TBL] [Abstract][Full Text] [Related]
39. Lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: an evolving concept.
Lin P; Medeiros LJ
Adv Anat Pathol; 2005 Sep; 12(5):246-55. PubMed ID: 16210920
[TBL] [Abstract][Full Text] [Related]
40. Transitions in CD45 isoform expression indicate continuous differentiation of a monoclonal CD5+ CD11b+ B lineage in Waldenstrom's macroglobulinemia.
Jensen GS; Andrews EJ; Mant MJ; Vergidis R; Ledbetter JA; Pilarski LM
Am J Hematol; 1991 May; 37(1):20-30. PubMed ID: 1708944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
